Literature DB >> 22684120

3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells.

Stefan T Yohe1, Victoria L M Herrera, Yolonda L Colson, Mark W Grinstaff.   

Abstract

In this work we expand upon a recently reported local drug delivery device, where air is used as a degradable component of our material to control drug release (J. Am. Chem. Soc. 2012, 134, 2016-2019). We consider its potential use as a drug loaded strip to provide both mechanical stability to the anastomosis, and as a means to release drug locally over prolonged periods for prevention of locoregional recurrence in colorectal cancer. Specifically, we electrospun poly(ε-caprolactone) (PCL) with the hydrophobic polymer dopant poly(glycerol monostearate-co-ε-caprolactone) (PGC-C18) and used the resultant mesh to control the release of two anticancer drugs (CPT-11 and SN-38). The increase in mesh hydrophobicity with PGC-C18 addition slows drug release both by the traditional means of drug diffusion, as well as by increasing the stability of the entrapped air layer to delay drug release. We demonstrate that superhydrophobic meshes have mechanical properties appropriate for surgical buttressing of the anastomosis, permit non-invasive assessment of mesh location and documentation of drug release via ultrasound, and release chemotherapy over a prolonged period of time (>90 days) resulting in significant tumor cytotoxicity against a human colorectal cell line (HT-29).
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684120      PMCID: PMC3878861          DOI: 10.1016/j.jconrel.2012.05.047

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  44 in total

Review 1.  Advancing the field of drug delivery: taking aim at cancer.

Authors:  Marsha A Moses; Henry Brem; Robert Langer
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

2.  Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.

Authors:  Frank A Scappaticci; Louis Fehrenbacher; Thomas Cartwright; John D Hainsworth; William Heim; Jordan Berlin; Fairooz Kabbinavar; William Novotny; Somnath Sarkar; Herbert Hurwitz
Journal:  J Surg Oncol       Date:  2005-09-01       Impact factor: 3.454

3.  Use of ultrasound imaging and fluoroscopic imaging to study gastric retention of enzyme-digestible hydrogels.

Authors:  W S Shalaby; W E Blevins; K Park
Journal:  Biomaterials       Date:  1992       Impact factor: 12.479

Review 4.  Drug-eluting polymer implants in cancer therapy.

Authors:  Agata A Exner; Gerald M Saidel
Journal:  Expert Opin Drug Deliv       Date:  2008-07       Impact factor: 6.648

5.  Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro.

Authors:  C L Erickson-Miller; R D May; J Tomaszewski; B Osborn; M J Murphy; J G Page; R E Parchment
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

Review 6.  Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

Authors:  R H Mathijssen; R J van Alphen; J Verweij; W J Loos; K Nooter; G Stoter; A Sparreboom
Journal:  Clin Cancer Res       Date:  2001-08       Impact factor: 12.531

7.  Development and characterization of a novel liposome-based formulation of SN-38.

Authors:  J Allen Zhang; Tong Xuan; Manjeet Parmar; Lan Ma; Sydney Ugwu; Shahid Ali; Imran Ahmad
Journal:  Int J Pharm       Date:  2004-02-11       Impact factor: 5.875

8.  Phase I and pharmacokinetic trial of weekly CPT-11.

Authors:  M L Rothenberg; J G Kuhn; H A Burris; J Nelson; J R Eckardt; M Tristan-Morales; S G Hilsenbeck; G R Weiss; L S Smith; G I Rodriguez
Journal:  J Clin Oncol       Date:  1993-11       Impact factor: 44.544

9.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

Review 10.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

View more
  26 in total

Review 1.  Multifunctional Electrospun Nanofibers for Enhancing Localized Cancer Treatment.

Authors:  Yike Fu; Xiang Li; Zhaohui Ren; Chuanbin Mao; Gaorong Han
Journal:  Small       Date:  2018-06-27       Impact factor: 13.281

2.  Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications.

Authors:  Jiajia Xue; Tong Wu; Yunqian Dai; Younan Xia
Journal:  Chem Rev       Date:  2019-03-27       Impact factor: 60.622

3.  Fabrication of electrospun polycaprolactone coated withchitosan-silver nanoparticles membranes for wound dressing applications.

Authors:  Tra Thanh Nhi; Huynh Chan Khon; Nguyen Thi Thu Hoai; Bui Chi Bao; Tran Ngoc Quyen; Vo Van Toi; Nguyen Thi Hiep
Journal:  J Mater Sci Mater Med       Date:  2016-09-12       Impact factor: 3.896

Review 4.  Polyglycerol Hyperbranched Polyesters: Synthesis, Properties and Pharmaceutical and Biomedical Applications.

Authors:  Alexandra Zamboulis; Eirini A Nakiou; Evi Christodoulou; Dimitrios N Bikiaris; Eleana Kontonasaki; Liliana Liverani; Aldo R Boccaccini
Journal:  Int J Mol Sci       Date:  2019-12-09       Impact factor: 5.923

5.  Tunable drug-loading capability of chitosan hydrogels with varied network architectures.

Authors:  Giuseppe Tronci; Hiroharu Ajiro; Stephen J Russell; David J Wood; Mitsuru Akashi
Journal:  Acta Biomater       Date:  2013-10-21       Impact factor: 8.947

Review 6.  Emerging Roles of Electrospun Nanofibers in Cancer Research.

Authors:  Shixuan Chen; Sunil Kumar Boda; Surinder K Batra; Xiaoran Li; Jingwei Xie
Journal:  Adv Healthc Mater       Date:  2017-12-06       Impact factor: 9.933

7.  Mussel-inspired protein-mediated surface functionalization of electrospun nanofibers for pH-responsive drug delivery.

Authors:  J Jiang; J Xie; B Ma; D E Bartlett; A Xu; C-H Wang
Journal:  Acta Biomater       Date:  2013-11-25       Impact factor: 8.947

8.  Fabricating Superhydrophobic Polymeric Materials for Biomedical Applications.

Authors:  Jonah Kaplan; Mark Grinstaff
Journal:  J Vis Exp       Date:  2015-08-28       Impact factor: 1.355

Review 9.  Superhydrophobic materials for biomedical applications.

Authors:  Eric J Falde; Stefan T Yohe; Yolonda L Colson; Mark W Grinstaff
Journal:  Biomaterials       Date:  2016-07-09       Impact factor: 12.479

10.  Triggered drug release from superhydrophobic meshes using high-intensity focused ultrasound.

Authors:  Stefan T Yohe; Jonathan A Kopechek; Tyrone M Porter; Yolonda L Colson; Mark W Grinstaff
Journal:  Adv Healthc Mater       Date:  2013-04-17       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.